Open AccessA prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients
Author(s) -
David W. Johnson,
Karen A. Herzig,
Ruth Gissane,
Scott B. Campbell,
Carmel M. Hawley,
Nicole M. Isbel
Publication year - 2001
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/16.9.1879
Subject(s) - medicine , peritoneal dialysis , erythropoietin , concomitant , hemodialysis , crossover study , intravenous iron , dialysis , prospective cohort study , gastroenterology , surgery , anemia , iron deficiency , placebo , pathology , alternative medicine
Concomitant iron supplementation is required in the great majority of erythropoietin (Epo)-treated patients with end-stage renal failure. Intravenous (i.v.) iron supplementation has been demonstrated to be superior to oral iron therapy in Epo-treated haemodialysis patients, but comparative data in iron-replete peritoneal dialysis (PD) patients are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom